Literature DB >> 3572787

Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.

D de Wied, O Gaffori, J P Burbach, G L Kovács, J M van Ree.   

Abstract

The potency of various C-terminal fragments of the neurohypophyseal hormone [Arg8]vasopressin [AVP-(1-9)] was determined using different avoidance behavioral test procedures in rats. Passive avoidance behavior was facilitated by these peptides. The fragments [Cyt6]AVP-(5-8) and [Cyt6]AVP-(5-9) were the most potent peptides tested after postlearning injection (consolidation) and preretention treatment (retrieval), respectively, after s.c. treatment. Comparable results were found when the peptides were injected into the lateral brain ventricle, but after this route of administration the peptides were about 3 to 4 order of magnitude more potent as compared to the s.c. route. Pentylenetetrazol-induced retrograde amnesia was reversed by AVP-(1-9) and various C-terminal fragments. In this respect [Cyt6] AVP-(5-9) and [pGlu4,Cyt6]-AVP-(4-9) appeared to be the most potent peptides. Injection of AVP-(1-9) and various C-terminal fragments after the acquisition of pole-jumping avoidance behavior induced resistance to extinction of the behavior. The fragment [pGlu4,Cyt6]AVP-(4-8) was the most potent peptide for this effect. Passive avoidance behavior was attenuated by s.c. administered oxytocin [OXT-(1-9)] and various C-terminal fragments. [pGlu4,Cyt6]-OXT-(4-9), [pGlu4,Cyt6]OXT-(4-8) and [Cyt6]OXT-(5-8) were the most potent of the peptides tested after postlearning administration, whereas [Cyt6]OXT-(5-9) was the most potent sequence after preretention injection. In all experiments the effects of the peptides were dose-dependent and of a long term nature. The results show that C-terminal fragments of the neurohypophyseal hormones potently modulate various aspects of memory processes, as assessed with different avoidance behaviors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572787

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Neurodevelopmental influences on the immune system reflecting brain pathology.

Authors:  Rolf Ekman; Rita Persson; Carol L. Nilsson
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

2.  Oxytocin reduces background anxiety in a fear-potentiated startle paradigm: peripheral vs central administration.

Authors:  Luke W Ayers; Galen Missig; Jay Schulkin; Jeffrey B Rosen
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

3.  Oxytocin reduces background anxiety in a fear-potentiated startle paradigm.

Authors:  Galen Missig; Luke W Ayers; Jay Schulkin; Jeffrey B Rosen
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

4.  Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum.

Authors:  Karina J Vargas; José M Sarmiento; Pamela Ehrenfeld; Carolina C Añazco; Carolina I Villanueva; Pamela L Carmona; Marianne Brenet; Javier Navarro; Werner Müller-Esterl; Carlos B González
Journal:  Differentiation       Date:  2009-01-20       Impact factor: 3.880

5.  Low doses of oxytocin facilitate social recognition in rats.

Authors:  P Popik; J Vetulani; J M van Ree
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 6.  Oxytocin: the great facilitator of life.

Authors:  Heon-Jin Lee; Abbe H Macbeth; Jerome H Pagani; W Scott Young
Journal:  Prog Neurobiol       Date:  2009-04-10       Impact factor: 11.685

7.  Self-soothing behaviors with particular reference to oxytocin release induced by non-noxious sensory stimulation.

Authors:  Kerstin Uvnäs-Moberg; Linda Handlin; Maria Petersson
Journal:  Front Psychol       Date:  2015-01-12

8.  Distinct BOLD Activation Profiles Following Central and Peripheral Oxytocin Administration in Awake Rats.

Authors:  Craig F Ferris; Jason R Yee; William M Kenkel; Kelly Marie Dumais; Kelsey Moore; Alexa H Veenema; Praveen Kulkarni; Allison M Perkybile; C Sue Carter
Journal:  Front Behav Neurosci       Date:  2015-09-17       Impact factor: 3.558

9.  Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing.

Authors:  Meera E Modi; Mark J Majchrzak; Kari R Fonseca; Angela Doran; Sarah Osgood; Michelle Vanase-Frawley; Eric Feyfant; Heather McInnes; Ramin Darvari; Derek L Buhl; Natasha M Kablaoui
Journal:  J Pharmacol Exp Ther       Date:  2016-05-23       Impact factor: 4.030

Review 10.  Neurobiology of Aggressive Behavior-Role of Autoantibodies Reactive With Stress-Related Peptide Hormones.

Authors:  Henning Vaeroy; Frida Schneider; Sergueï O Fetissov
Journal:  Front Psychiatry       Date:  2019-12-04       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.